Most findings relate to cellular energy metabolism or come from preclinical studies
Eyeballing the syringe markings
It has been observed to promote angiogenesis and stimulate granulation tissue formation, and accelerate extracellular matrix remodeling, particularly in models of skin, muscle, and gastrointestinal injury (Seiwerth et al
They have emerged as key therapeutic targets in diabetes and obesity research , ranging from GLP-1 analogs like Semaglutide (Ozempic/Wegovy) to dual and triple agonists (Retatrutide) that synergistically enhance glycemic control and promote weight loss
The key practical difference in tolerability: tirzepatides GIP component may partially offset some GI effects of GLP-1 agonism through GIPs effect on gastric motility which may explain why some patients who discontinue semaglutide due to GI side effects tolerate tirzepatide better, though this is not consistently demonstrated across all patients
Semaglutide GLP-1 is known to improve a patients body composition by helping them lose weight and shed excess fat, including stubborn belly fat